While it’s now a top source of biopharmaceutical innovation, we believe China’s biotech sector is still in its early stages.

For all the attention on U.S.-China AI competition, new studies point to China’s rapid rise in biotechnology, especially for ...

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for ...

The Subject Expert Committee (SEC) on Vaccines, operating under the Central Drugs Standard Control Organization (CDSCO), has ...

The row between pharma companies and the U.K. government over rebates has intensified, with the Association of the British Pharmaceutical Industry (ABPI) calling up its members to speak on the record, ...